The RSI Oscillator for ACTS moved out of oversold territory on September 16, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 1 similar instances when the indicator left oversold territory. In 1 of the 1 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +3.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where ACTS advanced for three days, in 24 of 31 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ACTS as a result. In 8 of 8 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for ACTS turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 3 similar instances when the indicator turned negative. In 3 of the 3 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
ACTS moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACTS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
ACTS broke above its upper Bollinger Band on October 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ACTS entered a downward trend on September 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
BE moved below its 50-day moving average on October 14, 2026 date and that indicates a change from an upward trend to a downward trend. In 31 of 36 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 86%.
The 10-day RSI Indicator for BE moved out of overbought territory on September 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 34 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.
The Momentum Indicator moved below the 0 level on October 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BE as a result. In 63 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
The Moving Average Convergence Divergence Histogram (MACD) for BE turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 38 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where BE advanced for three days, in 266 of 309 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
BE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 235 of 259 cases where BE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. BE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 42 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 44 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BE's P/B Ratio (48.077) is very high in comparison to the industry average of (7.632). BE's P/E Ratio (341.390) is considerably higher than the industry average of (54.807). Projected Growth (PEG Ratio) (0.594) is also within normal values, averaging (2.900). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (24.876) is also within normal values, averaging (8.019).
BE | ||
|---|---|---|
OUTLOOK RATING 1..100 | 62 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 100 Overvalued | |
PROFIT vs RISK RATING 1..100 | 42 | |
SMR RATING 1..100 | 44 | |
PRICE GROWTH RATING 1..100 | 40 | |
P/E GROWTH RATING 1..100 | 94 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ACTS | BE | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 5 days ago 85% |
| Stochastic ODDS (%) | 2 days ago 90% | 1 day ago 73% |
| Momentum ODDS (%) | 2 days ago 90% | 1 day ago 85% |
| MACD ODDS (%) | 2 days ago 90% | 1 day ago 84% |
| TrendWeek ODDS (%) | 2 days ago 86% | 1 day ago 84% |
| TrendMonth ODDS (%) | 2 days ago 65% | 1 day ago 84% |
| Advances ODDS (%) | 12 days ago 77% | 15 days ago 86% |
| Declines ODDS (%) | 5 days ago 86% | 1 day ago 84% |
| BollingerBands ODDS (%) | 2 days ago 90% | 1 day ago 80% |
| Aroon ODDS (%) | 2 days ago 90% | 1 day ago 90% |
A.I.dvisor tells us that ACTS and CIEN have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACTS and CIEN's prices will move in lockstep.
| Ticker / NAME | Correlation To ACTS | 1D Price Change % | ||
|---|---|---|---|---|
| ACTS | 100% | -1.29% | ||
| CIEN - ACTS | 12% Poorly correlated | -6.67% | ||
| COHR - ACTS | 11% Poorly correlated | -7.06% | ||
| BE - ACTS | 8% Poorly correlated | -6.34% | ||
| GPOR - ACTS | 8% Poorly correlated | +1.37% | ||
| AEIS - ACTS | 8% Poorly correlated | -5.57% | ||
More | ||||